Hexagon Nutrition promoter acquires 5,000 shares in open market
- Dr. Nikhil Kelkar acquired 5,000 equity shares of Hexagon Nutrition on September 18, 2026
- The open market purchase increased his stake from 17.28% to 17.29% of total voting capital
- Total shareholding rose to 2,12,47,468 shares from 2,12,42,468 shares previously
- Transaction was disclosed under Regulation 29(2) of SEBI (SAST) Regulations, 2011
- No encumbrances or pledges were associated with the acquired shares

*this image is generated using AI for illustrative purposes only.
Hexagon Nutrition disclosed that Dr. Nikhil Kelkar, its promoter and Joint Managing Director, acquired 5,000 equity shares through open market transactions on September 18, 2026.
The acquisition was made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction represents a marginal increase in the promoter’s stake in the listed nutrition products manufacturer.
Shareholding Details
Prior to this transaction, Dr. Kelkar held 2,12,42,468 equity shares, constituting 17.28% of the total share and voting capital. The purchase of 5,000 additional shares raised his holding to 2,12,47,468 shares.
| Metric | Before Acquisition | Acquisition | After Acquisition |
|---|---|---|---|
| Number of Shares | 2,12,42,468 | 5,000 | 2,12,47,468 |
| % of Voting Capital | 17.28% | 0.0041% | 17.29% |
The total equity share capital of Hexagon Nutrition remained unchanged at 12,29,18,109 shares following the trade. There were no encumbrances, pledges, or convertible securities involved in this specific transaction.
Regulatory Compliance
The disclosure was submitted to both the National Stock Exchange of India Limited and BSE Limited. Vedanti Vartak, the Company Secretary and Compliance Officer, signed off on the filing on behalf of the company. Dr. Kelkar also submitted the requisite disclosure form directly to the exchanges.
Historical Stock Returns for Hexagon Nutrition
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.06% | -2.80% | +4.76% | +47.24% | +47.24% | +47.24% |
Does this incremental purchase signal Dr. Kelkar's confidence in Hexagon Nutrition's upcoming quarterly earnings or a broader strategic shift in the company's market positioning?
How might this insider buying activity influence retail investor sentiment and short-term stock price volatility in the coming weeks?
Are there indications that other key promoters or board members are planning similar open market acquisitions to consolidate control or demonstrate confidence?

































